#95 Landmark Clinical Evidence
Peer-reviewed human research with direct implications for cannabis medicine practice.
๐ฅ The legal status of cannabis remains highly fragmented across U.S. jurisdictions, creating a complex landscape that directly affects clinical practice and patient care. While cannabis remains federally illegal under the Controlled Substances Act despite state-level legalization in many areas, healthcare providers are increasingly encountering patients using cannabis for symptom management, yet face significant barriers to evidence-based counseling due to lack of standardized clinical guidance and concern about federal reporting obligations. This legal-regulatory confusion complicates the physician’s role in risk-benefit discussions, particularly when patients may be self-treating pain, anxiety, or other conditions where cannabis efficacy remains uncertain or dose-dependent. Clinicians should recognize that their ability to obtain accurate use histories, provide informed recommendations, and document encounters is constrained by these contradictory legal frameworks, which may ultimately compromise patient safety. Practically, providers should consider establishing clear office policies regarding cannabis discussions, staying updated on their specific state
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: